Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
20.6M
-
Shares change
-
+6.46M
-
Total reported value, excl. options
-
$416M
-
Value change
-
+$131M
-
Number of buys
-
22
-
Number of sells
-
-6
-
Price
-
$20.24
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2016
32 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2016.
Ascendis Pharma A/S - ADR (ASND) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.6M shares
of 55.6M outstanding shares and own 37% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (5.41M shares), FMR LLC (3.15M shares), ORBIMED ADVISORS LLC (2.72M shares), Vivo Capital, LLC (1.77M shares), DEERFIELD MANAGEMENT CO (1.05M shares), BAKER BROS. ADVISORS LP (1.02M shares), EcoR1 Capital, LLC (976K shares), VHCP Management II, LLC (721K shares), JANUS CAPITAL MANAGEMENT LLC (594K shares), and ACUTA CAPITAL PARTNERS, LLC (575K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.